Evidence map›Paper›PMID 41400782›Full record

Trial reportJournal of assisted reproduction and genetics2026

Nonlinear association of serum luteinizing hormone on hCG trigger day with cumulative live birth in IVF cycles: secondary analysis of a randomized clinical trial.

Ling Guo, Binbin Zhao, Zirui Peng, Keke Wei, Zi-Jiang Chen, Junhao Yan, Yan Li, Xinbo Xu, Nan Lu, Yaxin Su

Registry-linked trialAbstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in Journal of assisted reproduction and genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03118141 (Cumulative Live Birth Rate With eSET After In-vitro Fertilization With Preim-plantation Genetic Screening by Next Generation Sequencing Versus Conventional In-vitro Fertilization), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03118141 naunknown statusnot on this map

Cumulative Live Birth Rate With eSET After In-vitro Fertilization With Preim-plantation Genetic Screening by Next Generation Sequencing Versus Conventional In-vitro Fertilization: A Pragmatic Randomized Controlled Clinical Trial

TypeinterventionalSponsorChen Zi-JiangRan2017 to 2020Enrolled1,215ConditionsInfertilityArmsblastocyst morphologic score, blastocyst biopsy and sequencing, freeze-all and single thawed blastocyst transfer
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ling Guo *Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, China.
Binbin Zhao *State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, 250012, China.
Zirui PengState Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, 250012, China.
Keke WeiState Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, 250012, China.
Zi-Jiang ChenState Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, 250012, China.
Junhao YanState Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, 250012, China.
Yan LiState Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, 250012, China.
Xinbo XuDepartment of Otolaryngology, Qilu Hospital of Shandong University, Jinan, Shandong, 250012, China. xuxinbo@sdu.edu.cn.
Nan LuMedical Integration and Practice Center, Shandong University, Jinan, Shandong, 250012, China. lunan@sdu.edu.cn.
Yaxin SuState Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, 250012, China. summersyx@126.com.ORCID http://orcid.org/0009-0002-9677-538X

Funding

the National Key Research and Development Program of China 2024YFC2706700the Taishan Scholars Program for Young Experts of Shandong Province tsqn202408396
6 · The paper itself

Abstract

purposeTo investigate the impact of serum luteinizing hormone (LH) levels on the day of human chorionic gonadotropin (hCG) trigger on cumulative live birth in women undergoing in vitro fertilization (IVF) cycles.

methodsThis was a secondary analysis of a multicenter randomized controlled trial (NCT03118141). A total of 1212 infertile women undergoing their first IVF cycle with a good prognosis for live birth were included. Participants were stratified into three groups according to tertiles of serum LH levels on the hCG trigger day (hLH): low-hLH (< 1.28 IU/L), medium-hLH (1.28-3.26 IU/L), and high-hLH (> 3.26 IU/L). Logistic regression and restricted cubic spline models were used to evaluate associations, adjusting for maternal age, body mass index, and baseline hormones.

resultsCompared to the medium-hLH group, the low-hLH group exhibited significantly lower cumulative clinical pregnancy and live birth rates, along with a higher biochemical pregnancy loss rate (P < 0.05). The high-hLH group demonstrated a reduced cumulative live birth rate, while other pregnancy outcomes were comparable to the medium-hLH group. A restricted cubic spline analysis revealed a significant nonlinear, inverted U-shaped relationship between serum hLH levels and cumulative live birth rates, with the optimal threshold around 1.95 IU/L. Stratified analysis indicated that the impact of hLH levels was more pronounced in women undergoing GnRH antagonist protocols.

conclusionsSerum hLH levels exhibit a nonlinear association with cumulative live birth rates in IVF cycles, highlighting 1.95 IU/L as a potential threshold. Individualized adjustment of hLH levels may improve pregnancy outcomes, especially in GnRH antagonist protocols.

Indexed as

Chorionic GonadotropinFertilization in VitroInfertility, FemaleLive BirthLuteinizing HormoneOvulation InductionAdultBirth RateFemaleHumansPregnancyPregnancy OutcomePregnancy RateChorionic GonadotropinLuteinizing HormoneCumulative live birth rateHuman chorionic gonadotropin triggerIn vitro fertilization-embryo transferLuteinizing hormoneOvarian stimulation

Identifiers

PMID41400782
PMCPMC12982701

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.